Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - a harmonized statement of allergy centers in Germany.

Literature DB >> 33521511

Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - a harmonized statement of allergy centers in Germany.

Margitta Worm¹, Andrea Bauer², Bettina Wedi³, Regina Treudler⁴, Wolfgang Pfuetzner⁵, Knut Brockow⁶, Timo Buhl⁷, Torsten Zuberbier⁸, Joachim Fluhr⁸, Gerda Wurpts⁹, Ludger Klimek¹⁰, Thilo Jacob¹¹, Hans F Merk¹², Norbert Mülleneisen¹³, Stefani Roeseler¹⁴, Heinrich Dickel¹⁵, Ulrike Raap¹⁶, Jörg Kleine-Tebbe¹⁷.

Abstract

Severe allergic reactions to vaccines are very rare. Single severe reactions have occurred worldwide after vaccination with the new mRNA-based COVID-19 vaccines. PEG2000 is discussed as a possible trigger. We provide guidance on risk assessment regarding COVID-19 vaccination in patients with allergic diseases and suggest a standardized, resource-oriented diagnostic and therapeutic procedure. Reports of severe allergic reactions in the context of COVID-19 vaccination can be made via www.anaphylaxie.net using an online questionnaire. © Dustri-Verlag Dr. K. Feistle.

Entities: Chemical Disease Gene Species

Keywords: COVID-19 vaccination; allergy; anaphylaxis; polyethylene glycol; polysorbate 80; skin test

Year: 2021 PMID： 33521511 PMCID： PMC7841415 DOI： 10.5414/ALX02225E

Source DB: PubMed Journal: Allergol Select ISSN： 2512-8957

9 in total

Review 1. Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).

Authors: Elio Novembre; Mariangela Tosca; Carlo Caffarelli; Mauro Calvani; Fabio Cardinale; Riccardo Castagnoli; Elena Chiappini; Claudio Cravidi; Michele Miraglia Del Giudice; Marzia Duse; Amelia Licari; Sara Manti; Alberto Martelli; Giampaolo Ricci; Giuseppe Pingitore; Gian Luigi Marseglia
Journal: Ital J Pediatr Date: 2022-05-16 Impact factor: 3.288

Review 2. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.

Authors: Farnoosh Seirafianpour; Homa Pourriyahi; Milad Gholizadeh Mesgarha; Arash Pour Mohammad; Zoha Shaka; Azadeh Goodarzi
Journal: Dermatol Ther Date: 2022-04-11 Impact factor: 3.858

3. Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2.

Authors: Vincenzo Restivo; Giuseppina Candore; Maria Barrale; Ester Caravello; Giorgio Graziano; Rosa Onida; Maurizio Raineri; Salvatore Tiralongo; Ignazio Brusca
Journal: Vaccines (Basel) Date: 2021-04-21

Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - a harmonized statement of allergy centers in Germany.

Review 1. Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).

Review 2. A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.

3. Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2.

4. Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: Limits of intradermal testing.

5. A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes.

6. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.

7. Vaccinating with a COVID-19 Vaccine: Experience of the Tertiary Allergology Center.

Review 8. Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19.

Review 9. Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review.